Olawale Ayilara, University of Manitoba

Research

Read how they describe their research on their University of Manitoba profile.

Latest papers

Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial.
Research and practice in thrombosis and haemostasis · 2025
Latent variable mixture models to address heterogeneity in patient-reported outcome data
Methods · 2022 · senior author
Mapping three versions of the international classification of diseases to categories of chronic conditions.
International journal of population data science · 2021

All 3 publications

Latest funding

Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)
CIHR · 2023 · Co-investigator
$5,500,001
Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)
CIHR · 2023 · Co-investigator
$1,375,000

All 2 grants and awards

3 publications.

01

Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial.

Lother SA, Teng W, Ayilara O, Houston BL, Rush B, Murthy S, Nicolau JC, Bond L, Turgeon AF, Marshall JC, Paul J, Hochman JS, Neal MD, Farkouh ME, Nkosi J, Houston DS, Bradbury CA, Mendelson AA, Goligher EC, Garland A, Balshaw R, Shaw SY, Lawler PR, Keynan Y, Zarychanski R

Research and practice in thrombosis and haemostasis2025Open Access

DOI: 10.1016/j.rpth.2025.102893 PMID: 40613068

02

Latent variable mixture models to address heterogeneity in patient-reported outcome data

Lisa Marie Lix, Olawale F. Ayilara

Methods20222 citationsSenior author

DOI: 10.1016/j.ymeth.2022.03.010 PMID: 35314340

03

Mapping three versions of the international classification of diseases to categories of chronic conditions.

Hamad AF, Vasylkiv V, Yan L, Sanusi R, Ayilara O, Delaney JA, Wall-Wieler E, Jozani MJ, Hu P, Banerji S, Lix LM

International journal of population data science202116 citationsOpen Access

DOI: 10.23889/ijpds.v6i1.1406 PMID: 34007901

Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects

Principal investigators: Zarychanski, Ryan; Lawler, Patrick R; Lother, Sylvain; McDonald, Emily G

Keywords: Bayesian Adaptive Trial; Community Acquired Pneumonia (Cap); Corticosteroids; Dexamethasone; Phase Iii Trial; Randomized Trial

$5,500,001

Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Zarychanski, Ryan; Lawler, Patrick R; Lother, Sylvain; McDonald, Emily G

Keywords: Bayesian Adaptive Trial; Community Acquired Pneumonia (Cap); Corticosteroids; Dexamethasone; Phase Iii Trial; Randomized Trial

$1,375,000

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Ryan Zarychanski and Alexis Turgeon: 99 shared papers
Ryan Zarychanski and Brett Houston: 61 shared papers
Ryan Zarychanski and Donald Houston: 51 shared papers
Ryan Zarychanski and Patrick Lawler: 41 shared papers
John Marshall and Srinivas Murthy: 41 shared papers
Brett Houston and Donald Houston: 40 shared papers
Michael Farkouh and Patrick Lawler: 39 shared papers
Alexis Turgeon and John Marshall: 37 shared papers
Ryan Zarychanski and John Marshall: 36 shared papers
Ryan Zarychanski and Sylvain Lother: 33 shared papers
Ewan Goligher and Patrick Lawler: 33 shared papers
Alexis Turgeon and Brett Houston: 29 shared papers
Ryan Zarychanski and Ewan Goligher: 28 shared papers
Ryan Zarychanski and Srinivas Murthy: 27 shared papers
Ryan Zarychanski and Allan Garland: 26 shared papers
Alexis Turgeon and Srinivas Murthy: 24 shared papers
Allan Garland and Brett Houston: 22 shared papers
Allan Garland and Donald Houston: 22 shared papers
Lisa Lix and Amani Hamad: 18 shared papers
Alexis Turgeon and Sylvain Lother: 17 shared papers
Lisa Lix and Allan Garland: 16 shared papers
Sylvain Lother and Brett Houston: 16 shared papers
Ryan Zarychanski and Michael Farkouh: 15 shared papers
Sylvain Lother and Barret Rush: 15 shared papers
Ryan Zarychanski and Asher Mendelson: 14 shared papers
Ryan Zarychanski and Robert Balshaw: 14 shared papers
Alexis Turgeon and Ewan Goligher: 14 shared papers
Michael Farkouh and Ewan Goligher: 14 shared papers
Brett Houston and Robert Balshaw: 14 shared papers
Asher Mendelson and Brett Houston: 12 shared papers
Yoav Keynan and Sylvain Lother: 11 shared papers
Sylvain Lother and Asher Mendelson: 11 shared papers
Allan Garland and Robert Balshaw: 11 shared papers
Souradet Shaw and Yoav Keynan: 10 shared papers
Ryan Zarychanski and Barret Rush: 8 shared papers
Srinivas Murthy and Yoav Keynan: 8 shared papers
Ryan Zarychanski and Lisa Lix: 7 shared papers
Lisa Lix and Mohammad Jafari Jozani: 7 shared papers
Alexis Turgeon and Barret Rush: 6 shared papers
Lisa Lix and Souradet Shaw: 5 shared papers
Lisa Lix and Pingzhao Hu: 5 shared papers
Lisa Lix and Shantanu Banerji: 5 shared papers
Amani Hamad and Pingzhao Hu: 5 shared papers
Amani Hamad and Mohammad Jafari Jozani: 5 shared papers
Pingzhao Hu and Mohammad Jafari Jozani: 5 shared papers
Amani Hamad and Shantanu Banerji: 4 shared papers
Pingzhao Hu and Shantanu Banerji: 4 shared papers
Ryan Zarychanski and Souradet Shaw: 3 shared papers
Lisa Lix and Olawale Ayilara: 2 shared papers
Ryan Zarychanski and Olawale Ayilara: 1 shared paper
Alexis Turgeon and Olawale Ayilara: 1 shared paper
Michael Farkouh and Olawale Ayilara: 1 shared paper
John Marshall and Olawale Ayilara: 1 shared paper
Srinivas Murthy and Olawale Ayilara: 1 shared paper
Ewan Goligher and Olawale Ayilara: 1 shared paper
Souradet Shaw and Olawale Ayilara: 1 shared paper
Yoav Keynan and Olawale Ayilara: 1 shared paper
Sylvain Lother and Olawale Ayilara: 1 shared paper
Patrick Lawler and Olawale Ayilara: 1 shared paper
Amani Hamad and Olawale Ayilara: 1 shared paper
Asher Mendelson and Olawale Ayilara: 1 shared paper
Pingzhao Hu and Olawale Ayilara: 1 shared paper
Mohammad Jafari Jozani and Olawale Ayilara: 1 shared paper
Allan Garland and Olawale Ayilara: 1 shared paper
Barret Rush and Olawale Ayilara: 1 shared paper
Shantanu Banerji and Olawale Ayilara: 1 shared paper
Brett Houston and Olawale Ayilara: 1 shared paper
Donald Houston and Olawale Ayilara: 1 shared paper
Robert Balshaw and Olawale Ayilara: 1 shared paper

Department of Internal Medicine
College of Community and Global Health
Department of Medicine
Family Medicine and Emergency Medicine
Department for the Study of Religion
Department of Statistics
Biostatistics Division
Other

1 shared papers, latest 2025

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Ayilara, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial." (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]